Polystyrene nanoparticles affecting blood coagulation

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 6, 2012, Pages 981-986

  Oslakovic, Cecilia ^a   Cedervall, Tommy ^a   Linse, Sara ^a   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Blood coagulation; Nanoparticle; Nanosafety; Nanotoxicology; Polystyrene

Indexed keywords

BIOLOGICAL PROCESS; BIOMODULATORY EFFECTS; BLOOD COAGULATION; DIAGNOSTIC METHODS; HUMAN PLASMAS; NANOSAFETY; NANOTOXICOLOGY; POLYSTYRENE NANOPARTICLES;

ENZYMES; NANOPARTICLES;

POLYSTYRENES;

AMINE; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CARBOXYL GROUP; NANOPARTICLE; POLYSTYRENE; THROMBIN;

ARTICLE; BLOOD CLOTTING; CHEMICAL MODIFICATION; CONTROLLED STUDY; HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN BINDING; PROTHROMBIN TIME; SURFACE PROPERTY; ZETA POTENTIAL;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; FIBRINOLYTIC AGENTS; HUMANS; MATERIALS TESTING; NANOPARTICLES; POLYSTYRENES;

EID: 84864083902     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.12.001     Document Type: Article

References (24)

1. Colvin VL The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2003, 21:1166-1170.
2. Lynch I, Dawson KA, Linse S Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006, 2006:pe14.
3. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA The nanoparticle-protein complex as a biological entity: a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 2007, 134-135:167-174.
4. Cedervall T., Lynch I., Lindman S., Berggård T., Thulin E., Nilsson H., et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 2007, 104:2050-2055.
5. Gessner A, Paulke BR, Muller RH Analysis of plasma protein adsorption onto polystyrene particles by two-dimensional electrophoresis: comparison of sample application and isoelectric focusing techniques. Electrophoresis 2000, 21:2438-2442.
6. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008, 105:14265-14270.
7. Gessner A, Waicz R, Lieske A, Paulke B, Mader K, Muller RH Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm 2000, 196:245-249.
8. Gessner A, Lieske A, Paulke B, Muller R Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 2002, 54:165-170.
9. Gessner A, Lieske A, Paulke BR, Muller RH Functional groups onpolystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res A 2003, 65:319-326.
10. Sperling C, Fischer M, Maitz MF, Werner C Blood coagulation on biomaterials requires the combination of distinct activation processes. Biomaterials 2009, 30:4447-4456.
11. Sperling C, Schweiss RB, Streller U, Werner C In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. Biomaterials 2005, 26:6547-6557.
12. Butenas S., Mann KG Blood coagulation. Biochemistry (Mosc) 2002, 67:3-12.
13. Dahlback B Blood coagulation. Lancet 2000, 355:1627-1632.
14. Gailani D, Renne T The intrinsic pathway of coagulation: a target for treating thromboembolic disease?. J Thromb Haemost 2007, 5:1106-1112.
15. Dahlback B Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med 2005, 257:209-223.
16. Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988, 71:335-343.
17. Dahlback B, Villoutreix BO The anticoagulant protein C pathway. FEBS Lett 2005, 579:3310-3316.
18. Krisinger MJ, Guo LJ, Salvagno GL, Guidi GC, Lippi G, Dahlback B Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma. Febs J 2009, 276:6586-6602.
19. Muller F, Mutch N.J., Schenk W.A., Smith S.A., Esterl L., Spronk H.M., et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009, 139:1143-1156.
20. Zhuo R, Siedlecki CA, Vogler EA Competitive-protein adsorption in contact activation of blood factor XII. Biomaterials 2007, 28:4355-4369.
21. Nemmar A, Hoylaerts M.F., Hoet P.H., Dinsdale D., Smith T., Xu H., et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002, 166:998-1004.
22. Hoet PH, Bruske-Hohlfeld I, Salata OV Nanoparticles - known and unknown health risks. J Nanobiotechnology 2004, 2:12.
23. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 2005, 146:882-893.
24. Luck M, Paulke BR, Schroder W, Blunk T, Muller RH Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res 1998, 39:478-485.